Initiator Pharma A/S (INIT)

Stockholm
Currency in SEK
3.6800
-0.0200(-0.54%)
Closed·
INIT Scorecard
Full Analysis
Management has been aggressively buying back shares
INIT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.65003.8100
52 wk Range
3.55009.4000
Key Statistics
Edit
Prev. Close
3.7
Open
3.81
Day's Range
3.65-3.81
52 wk Range
3.55-9.4
Volume
16.81K
Average Volume (3m)
73.66K
1-Year Change
-60.22%
Book Value / Share
0.31
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
INIT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Initiator Pharma Company Profile

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. Its product pipeline includes Pudafensine, a monoamine reuptake inhibitor primarily targeting the dopamine system for both treatment resistant organic erectile dysfunction and neuropathic pain in Phase 2b clinical trials; IP2018, a monoamine reuptake inhibitor completed Phase 2a for the treatment of psychogenic erectile dysfunction; and IP2016, which is in preclinical development for the treatment of depression and pain. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.

Compare INIT to Peers and Sector

Metrics to compare
INIT
Peers
Sector
Relationship
P/E Ratio
−14.7x−3.6x−0.5x
PEG Ratio
−0.38−0.050.00
Price/Book
13.9x1.2x2.6x
Price / LTM Sales
-6.5x3.1x
Upside (Analyst Target)
264.8%644.3%45.7%
Fair Value Upside
Unlock10.3%5.7%Unlock

Earnings

Latest Release
May 09, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

INIT Income Statement

FAQ

What Is the Initiator Pharma (INIT) Stock Price Today?

The Initiator Pharma stock price today is 3.68.

What Stock Exchange Does Initiator Pharma Trade On?

Initiator Pharma is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Initiator Pharma?

The stock symbol for Initiator Pharma is "INIT."

What Is the Initiator Pharma Market Cap?

As of today, Initiator Pharma market cap is 251.12M.

What Is Initiator Pharma's Earnings Per Share (TTM)?

The Initiator Pharma EPS (TTM) is -0.20.

From a Technical Analysis Perspective, Is INIT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Initiator Pharma Stock Split?

Initiator Pharma has split 3 times.

How Many Employees Does Initiator Pharma Have?

Initiator Pharma has 2 employees.

What is the current trading status of Initiator Pharma (INIT)?

As of 09 Jul 2025, Initiator Pharma (INIT) is trading at a price of 3.68, with a previous close of 3.70. The stock has fluctuated within a day range of 3.65 to 3.81, while its 52-week range spans from 3.55 to 9.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.